China SXT Pharmaceuticals, Inc. (SXTC) hisse senedi — iyi bir şirket mi?

China SXT Pharmaceuticals, Inc. (SXTC) hisse senedi — iyi bir şirket mi? — InspectStocks

Keep exploring

The themes China SXT Pharmaceuticals is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Drug Manufacturers Specialty and Generic

Graded A or B and worth $2B or more: A first, then the largest.

All 78 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Nasıl para kazanıyor

Regular traditional Chinese medicine pieces%95
Advanced traditional Chinese medicine pieces%4

Gelir payları year ended March 31, 2026 dönemi için tahmindir; resmî bir bildirimden alınmış rakamlar değildir.

Rekabet ettiği şirketler

600518Kangmei Pharmaceutical Co., Ltd.
300147Xiangxue Pharmaceutical Co., Ltd.

Ne satıyor6

Regular traditional Chinese medicine pieces
Medicinal plants processed into forms such as cut pieces or powders, generally prepared by boiling or decoction before use.
Directly-Oral advanced TCMP
Processed herbal medicines made to be taken by mouth without first being boiled as a decoction.
After-Soaking-Oral advanced TCMP
Small sealed bags of herbal material steeped in hot water to make an infusion.

3 tane daha göster

SanQiFen
A directly swallowed powder made from the roots and rhizomes of notoginseng.
CuYanHuSuo
A directly swallowed powder made from the tubers of Corydalis yanhusuo.
LuXueJing
A directly swallowed product made from dried deer blood.

Kim alıyor3

Hospitals, especially traditional Chinese medicine hospitals, buy products for patient care, mainly in Jiangsu province.
Pharmaceutical wholesalers buy products and distribute them to hospitals and other healthcare distributors.
As of March 31, 2026, end customers included 46 pharmaceutical companies, 11 chain pharmacies and 12 hospitals (March 31, 2026, high).

Neye dayanıyor ve onu ne yıkabilir

Faaliyetin dayandığı şeyler

1Relies on medicinal-plant raw materials supplied by vendors in China.
2Relies on a limited number of customers; hospitals and pharmaceutical distributors account for important sales channels.
3Its business in China depends on contractual arrangements with Taizhou Suxuantang, a variable interest entity, rather than direct ownership of that operating company.

Ters gidebilecekler

1Losing or reducing sales to a small number of major customers could harm revenue.
2Disruptions in the supply of medicinal plants or other raw materials could interrupt production and deliveries.
3The company may be unable to enforce its contractual arrangements with Taizhou Suxuantang, or changes in Chinese rules may affect those arrangements or its ability to operate.

Tüm finansal tablolar →

China SXT Pharmaceuticals, Inc. hakkında

China SXT makes traditional Chinese medicine pieces (TCMP) from medicinal plants, including herbs prepared as powders and other forms. In the fiscal year ended March 31, 2026, regular TCMP made up 95.02% of revenue (FY2026, high), while advanced TCMP made up 4.35% (FY2026, high); some advanced products can be swallowed directly or steeped in hot water. Total revenue was $1,138,052 (year ended March 31, 2026, high).

Merkez: Taizhou, Jiangsu, China
Kuruluş: 2017
Çalışan sayısı: 56 full-time employees (March 31, 2026, high)
İşlem gördüğü borsa: Nasdaq Capital Market
Mali yıl sonu: March 31

China SXT Pharmaceuticals, Inc. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.

Keep exploring

The themes China SXT Pharmaceuticals is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.